Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data.

It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.

The market opens at 10am (eastern time) and the data is taken at 10:15am, once every ASX stock has started trading.



Stocks highlighted in yellow have made market-moving announcements (click headings to sort).

WordPress Tables Plugin

Avecho Biotechnology (ASX:AVE) signed an agreement with NYSE-listed Perrigo Company for the development of a TPM-enhanced ibuprofen gel product for the US market.

Perrigo will conduct a clinical trial in a pain-related indication using the ibuprofen TPM gel in 2023. If successful, it has the potential to be the first topical ibuprofen product approved in the U.S.

Lithium drilling across Forrestania Resources’ (ASX:FRS) namesake project in WA will kick off next month.

And metallurgical results show that Meteoric Resources’ (ASX:MEI) new Caldeira project does indeed contain ionic adsorption clay REEs.

“These results show a considerable portion of the target REEs are adsorbed onto clays allowing for recovery by a simple washing process, unlike the case for many REE projects, where the REEs are tightly bound within the mineral lattice or are even in colloidal suspension requiring a much more intensive treatment process,” MEI says.



Stocks highlighted in yellow have made market-moving announcements (click headings to sort).

WordPress Tables Plugin